RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @drljbaldwin: Interesting Cochrane review results: https://t.co/cThViQigKt Follow the Altmetric link to see how people are interpreting …
RT @Fbeijamini: Methylphenidate has been used to treat ADHD all around world, however, we don’t have good evidences of its efficacy https:/…
Methylphenidate has been used to treat ADHD all around world, however, we don’t have good evidences of its efficacy https://t.co/MrvqUUk2w2
New review on ADHD and Methylphenidate in @CochraneLibrary https://t.co/1QobrjhW8S - is it just placebo?
RT @drljbaldwin: Interesting Cochrane review results: https://t.co/cThViQigKt Follow the Altmetric link to see how people are interpreting …
Interesting Cochrane review results: https://t.co/cThViQigKt Follow the Altmetric link to see how people are interpreting it though! ...
#Methylphenidate for children & adolescents wth attention deficit hyperactivity disorder (#ADHD); #Cochrane Library https://t.co/0sLfdCYoZ7
RT @AETSA_: #Rev_Sist Persisten dudas uso #metilfenidato en #TDAH (Déficit Atención e Hiperactividad) https://t.co/Ha2Ml2p0ic @feaadah @SEP…
RT @AETSA_: #Rev_Sist Persisten dudas uso #metilfenidato en #TDAH (Déficit Atención e Hiperactividad) https://t.co/Ha2Ml2p0ic @feaadah @SEP…
#Rev_Sist Persisten dudas uso #metilfenidato en #TDAH (Déficit Atención e Hiperactividad) https://t.co/Ha2Ml2p0ic @feaadah @SEPEAP @_ASEPCO
#Cochrane review raises questions on #Methylphenidate for #ADHD https://t.co/ei7Lo5U9du
#Cochrane review raises questions on #Methylphenidate for #ADHD https://t.co/NfF6pA7pnr
RT @dr_mesutcetin: DEHB'de metilfenidat kullanımı: Çok tartışılacak bir metaanalizThe Cochrane Library - Storebø - Wiley Online Library htt…
Hepatocyte receptor for Malarial parasite found https://t.co/0IuVPAiRAy
RT @dr_mesutcetin: DEHB'de metilfenidat kullanımı: Çok tartışılacak bir metaanalizThe Cochrane Library - Storebø - Wiley Online Library htt…
DEHB'de metilfenidat kullanımı: Çok tartışılacak bir metaanalizThe Cochrane Library - Storebø - Wiley Online Library https://t.co/6hLBHhlYMh
RT @ThomasPattyn: 1 ADHD verantwoordelijk per provincie. Mss ook eens de Cochrane nakijken wat de evidence is? @Maggie_DeBlock https://t.c…
RT @ThomasPattyn: 1 ADHD verantwoordelijk per provincie. Mss ook eens de Cochrane nakijken wat de evidence is? @Maggie_DeBlock https://t.c…
1 ADHD verantwoordelijk per provincie. Mss ook eens de Cochrane nakijken wat de evidence is? @Maggie_DeBlock https://t.co/4jrjQJJv2j
Caution urged in prescribing Ritalin to treat ADHD. Abridged version of this Cochrane Review in the BMJ this week. https://t.co/bfQyecAhX9
@Beyond_ADHD Cochrane Review: https://t.co/1UvFmXWwNf Methylphenidate does NOT work. Many of us who treat ADD knew this. @AllenFrancesMD
Methylphenidate for children & adolescents #ADHD https://t.co/M2e9hwc5oJ New #Cochrane review urges caution in the use of #Ritalin
RT @UKCochraneCentr: Caution urged over Ritalin for #ADHD as new #CochraneEvidence shows uncertainties https://t.co/PfcQDAl5J2
(Cochrane) Eficacia y seguridad de metilfenidato en niños y adolescentes con TDAH:necesaria evidencia de más calidad https://t.co/JbPncZ30P6
Evidence for Ritalin for ADHD "of very poor quality" https://t.co/q7Ss8cKtEa. 1 million prescriptions 2014. Is this the healthcare we want?
Twijfel over studies naar werking ADHD-medicijn https://t.co/VxyfQxKdR3 via @destandaard De Bron: https://t.co/NYu5f7mUpP
New Cochrane systematic review on Methylphenidate for children and adolescents with ADHD https://t.co/GWRsbQzEAj https://t.co/wU89tjLZLy
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @Pharmaforkids: New @cochranecollab review #methylphenidate for #ADHD. Some evidence of benefit, mild harms, better studies needed, http…
RT @Babir1981: Cochrane review: Methylphenidate for children and adolescents with ADHD https://t.co/0WqMzfqVu3
RT @thierrysouccar: La Ritaline, prescrite à des millions d'enfants hyperactifs n'est peut-être pas plus efficace qu'un placebo. https://t…
Review of 185 randomized trials advises more caution for prescribing #ADHD drugs https://t.co/VveidL7asE
RT @HospChiefPharm: Methylphenidate for children/adolescents with attention deficit hyperactivity disorder (ADHD) The Cochrane Library ht…
La Ritaline, prescrite à des millions d'enfants hyperactifs n'est peut-être pas plus efficace qu'un placebo. https://t.co/kWSz2h4BtP
Methylphenidate for children/adolescents with attention deficit hyperactivity disorder (ADHD) The Cochrane Library https://t.co/udzA1iVPaJ
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) https://t.co/9TYykBxqG3
RT @CaulfieldTim: Benefits/harms of methylphenidate for ADHD https://t.co/dMxNPd5Jbp adverse events & low quality evidence
RT @CaulfieldTim: Benefits/harms of methylphenidate for ADHD https://t.co/RvqYMtP3Hf adverse events & low quality evidence @EvidenceNetwork…
Benefits/harms of methylphenidate for ADHD https://t.co/RvqYMtP3Hf adverse events & low quality evidence @EvidenceNetwork @HealthyDebate
#ADHD #methylfenidaat preventie ellende moeilijk te bewijzen https://t.co/lrtihQ0HHG
New Cochrane Review - Researchers urge caution in prescribing commonly used drug to treat ADHD - https://t.co/QST3Z7Tl8D
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @CochraneLibrary: Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
Just published: #CochraneReview urges caution in prescribing commonly used drug to treat #ADHD https://t.co/UO2nioYEW6
RT @ukcochranecentr: Ritalin Risks/benefits for #ADHD in children unclear https://t.co/j9ErsRxvMq #CochraneEvidence https://t.co/p6IbJV8jRA
New Cochrane review on Methylphenidate for children with ADHD: «Better designed trials are needed» https://t.co/J8FRi9kdHp
New @cochranecollab review #methylphenidate for #ADHD. Some evidence of benefit, mild harms, better studies needed, https://t.co/DIJTHySxrl
Benefits and harms of methylphenidate for children and adolescents with attention deficit hyperactivity disorder... https://t.co/Pu7H9QE4PC
Benefits and harms of methylphenidate for children and adolescents with attention deficit hyperactivity disorder. https://t.co/u2Cngp9Qo0
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) - https://t.co/evW7dLqQpz
@cochranecollab Ritalin does help children concentrate at school - but benefits must be weighed against side effects https://t.co/Mm78FLLj2U
Methylphenidate in ADHD- do doubtful benefits outweigh sleep disturbances & loss of apetite? New #CochraneEvidence https://t.co/d75JSBmVgW
Benefits and harms of methylphenidate for children and adolescents with attention deficit… https://t.co/sHhVmvItB1
Why questions persist over benefit of methyphenidate in #ADHD despite 185 trials. New @CochraneLibrary review https://t.co/GcoGbC2bu5
Cochrane report: on average 526 in every 1000 children experienced unpleasant side-effects. https://t.co/3LXdlI0MNS https://t.co/dWXPqC7iXT
MT @UKCochraneCentr: Effects of methylphenidate for #ADHD uncertain https://t.co/1Qr301kvUM New #CochraneEvidence https://t.co/nVvYKDrdjE
Eficacia del Metilfenidato en el TDAH. Revisión Cochrane (Nov). https://t.co/FqB0WwEoqt
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD) https://t.co/60xJzBP1Z4
@kykaree @BBCNews Agree, pendulum swings: prescribe/not prescribe, but quality of evidence appears low https://t.co/G8xOBH2eTL